Hikma Eyes Return To Growth After Further Cutting Generics Forecasts

Injectables And Branded Increases Offset 18% Sales Slide For Generics Unit In First Half

 
• By David Wallace
  
Light at the end of the tunnel, red
Hikma sees light at the end of the tunnel for its generics business • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business